Sana Pharma also provides
- Technical opinion concerning the registrability of products or manufacturing sites through the review of the product dossiers, Drug Master Files, Site Master Files.
- Expert reports for clinical and none clinical studies and summaries (CTD modulesII, IV & V).
- Periodic safety update reports (PSUR).
- Our qualified experts are ready to work as independent party for inspection of API’s
or pharmaceutical manufacturing sites for regulatory purposes.